Hideyuki Hirama, MBA, was appointed Representative Director, President of Shin Nippon Biomedical Laboratories Ltd. in 2026. Mr. Hirama began his career in 2000 with the Industrial Bank of Japan (currently Mizuho Financial Group), building a strong foundation in finance. He joined Shin Nippon Biomedical Laboratories Ltd. in 2004, advancing to serve as Chief Financial Officer of SNBL USA, deepening his expertise in corporate finance and global operations. In 2019, Mr. Hirama founded Gemseki, assuming the role of President & CEO. From 2021 to 2026, he was with Rakuten Group, taking on senior leadership responsibilities and further honing his skills in global strategy, operations, and organizational leadership. Mr. Hirama returned to Shin Nippon Biomedical Laboratories Ltd. in 2026 as Representative Director, President. Mr. Hirama received an M.B.A. from Harvard Business School.
